drugset / Trial / NCT01300078
A Clinical Trial Assessing Safety of MF101 for Hot Flushes
RandomizedParallel-groupOpen-labelTreatment
Summary
This Phase 1, open label, randomized clinical trial will enroll 40 generally healthy, postmenopausal women aged 40-65 years old. Women will be randomized to one of two oral doses of MF101 for 4 weeks. Participants will be recruited at 3 clinical sites in the United States.
Timeline
- Start
- 2011-03
- Primary completion
- 2011-06
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MF101 | Traditional medicine (herbal / TCM) | 10 g | Oral |
| Subject | MF101 | Traditional medicine (herbal / TCM) | 15 g | Oral |
Indications
No indication recorded.